JOHNSON & JOHNSON SERVICES INC.
Market Reports 📊 143 Reports
126. Global Market for Pain Management Patches
The report will provide details about the pain management drugs used in the form of patches for immediate relief from any type of pain.
127. OTC Drugs, Medical Devices and Diagnostics: Global Markets
Get an overview of the global markets for over-the-counter (OTC) drugs, medical devices and diagnostics. Analyses of global market trends with data from 2018 to 2019, and projections of compound annua
128. Medical Devices Industry Competitive Landscape for the year 2019
The current report provides detailed competitive landscape of top 100 medical device manufacturers in the global market.
129. Internet of Things (IoT) in Healthcare
The global market for IoT in healthcare should grow from $82.3 billion in 2020 to $242.1 billion by 2025 at compound annual growth rates (CAGR) of 24.1% for the period of 2020-2025.
130. Stress Management Industry: Global Trends
The global stress management treatments market should reach $20.6 billion by 2024 from $17.2 billion in 2019 at a compound annual growth rate (CAGR) of 3.7% for the forecast period of 2019 to 2024.
131. Latest Development, Product Innovations and Treatments for Diabetes
The global diabetes treatment market should grow from $80.9 billion in 2019 to $103.2 billion by 2024 at a compound annual growth rate (CAGR) of 5.0% for the period of 2019-2024.
132. Global Dental Markets: Furniture, Equipment, Materials and Supplies
The global market for dental equipment, materials and supplies should grow from $60.5 billion in 2019 to reach $70.8 billion by 2024 at a compound annual growth rate (CAGR) of 3.2% for the period of 2
133. ROI in Pharmaceutical R&D: How to Halt the Decline
The global orphan drugs market should reach $315.6 billion by 2024 from $127.5 billion in 2017 at a compound annual growth rate (CAGR) of 13.8% for the forecast period of 2017 to 2024.
134. Global Electromedical Devices Market
The global market for electromedical devices reached $41.3 billion in 2018 and should reach $58.5 billion by 2023, at a compound annual growth rate (CAGR) of 7.2% for the period of 2018-2023.
135. Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies should grow from $346 billion in 2019 to $490 billion by 2024, at a compound annual growth rate (CAGR) of 7.2% fro
136. Surgical Devices Market: A BCC Research Overview
The global surgical devices market should grow from $85.5 billion in 2019 to reach $138.5 billion by 2024 at a compound annual growth rate (CAGR) of 10.1% for the period of 2019-2024.
137. Latest Innovations in Medical Device Technologies
The global market for medical device should grow from $470.5 billion in 2018 to reach $640.9 billion by 2023 at a compound annual growth rate of 6.4% for the period of 2018-2023.
138. Neurology Market: A BCC Research Overview
The global market for neurology should grow from $33.3 billion in 2019 to $39.4 billion by 2024 at a compound annual growth rate (CAGR) of 3.5% for the period of 2019-2024.
139. Markets at a Glance: Pharmaceuticals
Examine the trends revolutionizing the pharmaceuticals sector along with an overview of active pharmaceutical ingredients (API), antipsychotic drugs, and neuroprotective agents.
140. Markets at a Glance: Pharmaceuticals
Examine the trends revolutionizing the pharmaceuticals sector along with an overview of active pharmaceutical ingredients (API), antipsychotic drugs, and neuroprotective agents.
141. Internet of Things (IoT) Markets: A Global Outlook
Analyze the Internet of Things (IoT) global market size with data from 2017, 2018 and projections of compound annual growth rates (CAGRs) through 2023.
142. Colorectal Cancer Therapeutics: Global Markets
The global colorectal cancer therapeutics market should reach $18.5 billion by 2023 from $13.7 billion in 2018 at a compound annual growth rate of 6.1% for the period 2018 to 2023.
143. Antihypertensives: Global Markets to 2023
The global market for antihypertensive drugs should grow from nearly $26.3 billion in 2018 to $27.8 billion by 2023 with a compound annual growth rate (CAGR) of 1.1% for the period of 2018-2023.